Apollomics Inc. Class A Ordinary Shares logo

APLM Earnings Date: Dec 21, 2026 (Estimated) — Apollomics Inc. Class A Ordinary Shares

XNAS · Healthcare · Biotechnology

Updated

Price $21.34
Market Cap $62.2M
P/E —
52W Range $10.01 – $42.12
Next Earnings · After close (est.)

When is APLM's next earnings date?

Apollomics Inc. Class A Ordinary Shares (APLM) is expected to report H1 2026 earnings on Monday, December 21, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company.

How did APLM do in its last earnings report?

In its most recent report on Apr 27, 2026 (FY 2025), Apollomics Inc. Class A Ordinary Shares posted EPS of -$7.57. Revenue was $8.5M. The stock's 1-day post-earnings move was -0.7%.

How much does APLM stock move after earnings?

Over the last 6 reports the stock moved an average of 8.6% (up or down) in the day after earnings.

About Apollomics Inc. Class A Ordinary Shares

Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia. Company has three new immuno-oncology product candidates: APL-501, APL-502 and APL-801 include mono-specific and bi-specific antibodies to fight against cancer.

Earnings History

DatePeriodEPS Est.EPS Act.SurpriseRevenueResult1D Δ1W Δ1M Δ
2026-04-27FY 2025—-7.57—$8.5M—-0.69%+22.12%+6.08%
2025-12-22H1 2025—-11.37—$8,500—-6.81%+11.84%-2.65%
2025-04-03FY 2024—-52.80—$0—-10.58%-9.09%-9.24%
2024-08-14H1 2024—-38.00—$0—-4.56%-9.68%-5.91%
2024-03-28FY 2023—-232.00—$0—+23.97%+0.81%-25.62%
2023-09-28H1 2023—-255.00—$0—-4.95%-22.34%-78.12%

Showing last 6 quarters.

Related Companies

Learn More

Explore More

Financial data from licensed market-data providers; risk factors from SEC EDGAR filings. AI-powered analysis. Data last updated .